These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 8162173

  • 1. Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome.
    van Wijk PA, Rijnberk A, Croughs RJ, Wolfswinkel J, Selman PJ, Mol JA.
    Eur J Endocrinol; 1994 Apr; 130(4):410-6. PubMed ID: 8162173
    [Abstract] [Full Text] [Related]

  • 2. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 3. Chronic stress and pituitary-adrenocortical responses to corticotropin-releasing hormone and vasopressin in female pigs.
    Janssens CJ, Helmond FA, Wiegant VM.
    Eur J Endocrinol; 1995 Apr; 132(4):479-86. PubMed ID: 7711887
    [Abstract] [Full Text] [Related]

  • 4. Corticotropin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism.
    Van Wijk PA, Rijnberk A, Croughs RJ, Voorhout G, Sprang EP, Mol JA.
    Endocrinology; 1992 Dec; 131(6):2659-62. PubMed ID: 1332844
    [Abstract] [Full Text] [Related]

  • 5. Hyperadrenocorticism in a dog due to ectopic secretion of adrenocorticotropic hormone.
    Galac S, Kooistra HS, Voorhout G, van den Ingh TS, Mol JA, van den Berg G, Meij BP.
    Domest Anim Endocrinol; 2005 Apr; 28(3):338-48. PubMed ID: 15760674
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW, Verleun T, Oosterom R, de Jong F, Hackeng WH.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [Abstract] [Full Text] [Related]

  • 7. Adrenocorticotropic hormone and cortisol response to corticotropin-releasing factor and lysine vasopressin in pigs.
    Minton JE, Parsons KM.
    J Anim Sci; 1993 Mar; 71(3):724-9. PubMed ID: 8385088
    [Abstract] [Full Text] [Related]

  • 8. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
    Galac S, Kars VJ, Voorhout G, Mol JA, Kooistra HS.
    Vet J; 2008 Jul; 177(1):141-3. PubMed ID: 17572120
    [Abstract] [Full Text] [Related]

  • 9. Alterations in anterior pituitary function of dogs with pituitary-dependent hyperadrenocorticism.
    Meij BP, Mol JA, Bevers MM, Rijnberk A.
    J Endocrinol; 1997 Sep; 154(3):505-12. PubMed ID: 9379128
    [Abstract] [Full Text] [Related]

  • 10. Residual pituitary function after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism.
    Meij BP, Mol JA, Bevers MM, Rijnberk A.
    J Endocrinol; 1997 Dec; 155(3):531-9. PubMed ID: 9487998
    [Abstract] [Full Text] [Related]

  • 11. CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.
    Cantalamessa L, Catania A, Baldini M, Orsatti A, Motta P, Peracchi G.
    Horm Metab Res; 1990 Jul; 22(7):389-93. PubMed ID: 2169450
    [Abstract] [Full Text] [Related]

  • 12. Biochemical characterization of pituitary-dependent hyperadrenocorticism in the dog.
    Meijer JC, de Bruijne JJ, Rijnberk A, Croughs RJ.
    J Endocrinol; 1978 Apr; 77(1):111-8. PubMed ID: 205621
    [Abstract] [Full Text] [Related]

  • 13. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [Abstract] [Full Text] [Related]

  • 14. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K, Yoshinaga K.
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [Abstract] [Full Text] [Related]

  • 15. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B, Sala C, Bochicchio D, Colombo P, Gazzano G, Fadin C, Morganti A, Faglia G.
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987 May; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

  • 17. Effects of corticotropin-releasing hormone, lysine vasopressin, oxytocin, and angiotensin II on adrenocorticotropin secretion from porcine anterior pituitary cells.
    Abraham EJ, Minton JE.
    Domest Anim Endocrinol; 1996 May; 13(3):259-68. PubMed ID: 8738867
    [Abstract] [Full Text] [Related]

  • 18. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
    Murakami N, Fukata J, Usui T, Naito Y, Tominaga T, Nakai Y, Masui Y, Nakao K, Imura H.
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [Abstract] [Full Text] [Related]

  • 20. ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome.
    Langlois DK, Fritz MC, Schall WD, Bari Olivier N, Smedley RC, Pearson PG, Bailie MB, Hunt SW.
    BMC Endocr Disord; 2018 May 02; 18(1):24. PubMed ID: 29720169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.